Ozempic maker Novo Nordisk ousts CEO amid plunging share price as rival Eli Lilly gains market share

1 day ago Business NY Post - Business 9

Novo's shares have plunged since hitting a record-high in June last year as competition, particularly from Eli Lilly, makes inroads into its market share and as its pipeline of new drugs has failed to impress investors.

Read The Rest at : NY Post - Business

Top News

Matthews helps Leafs top Panthers, force Game 7
Auston Matthews got his first goal of the series to break a scoreless tie in the third period and the Toronto Maple Leafs kept their season alive...
Wellness influencer allegedly stole $2.3M from prominent real estate investor ‘role models’ to splurge on designer goods, personal shopper
Bobbi Vargas, 46, allgedly made nearly $450,000 in fraudulent Amazon purchases using credit cards from the high-profile couple she called her "role...
Shirtless illegal immigrant busted by ICE after jumping headfirst into pond in wild caught-on-camera pursuit
Valladares-Sierra, who was previously deported, had a pending court case where he is facing charges for resisting a public officer and driving...
Fever's Clark on entering Year 2: 'I know I belong'
As she embarks on her second season in the WNBA, Fever star Caitlin Clark likened her rookie year to being a freshman in high school and then...
Knicks pound Celtics by 38 to reach East finals
The Knicks reached the Eastern Conference finals for the first time in 25 years and ended the one-year NBA title reign of the Celtics with...
Report: Rory driver ruled nonconforming at PGA
Rory McIlroy was forced to use a backup driver in the PGA Championship when his regular driver was tested and deemed to be nonconforming after he...